KDMN | Kadmon Holdings Inc 4.91 -0.03 (-0.53%)
Category: Consumer goods
Quick infos Headquarters: United States Trade prices Volume: Market Cap: 845.34M Prev closed: 4.88 Open: 4.99 High: 4.99 Low: 4.75 52 week low: 2.3 52 week high: 5.73 Dividends: No Dividends Next ER: March 11, 2021
Company Profile Kadmon is a fully integrated biopharmaceutical company engaged in the discovery, development and commercialization of small molecules and biologics to address disease areas of significant unmet medical need. We are developing product candidates within autoimmune and fibrotic diseases, oncology and genetic diseases. We leverage our multi-disciplinary research and clinical development team members, who prior to joining Kadmon had brought more than 15 drugs to market, to identify and pursue a diverse portfolio of novel product candidates, through in-licensing products and employing our small molecule and biologics platforms.
Earnings History Date EPS / Forecast Revenue / Forecast May 13, 2021 March 5, 2021 -0.17 / -0.1667438K / 401.17KBeat! November 5, 2020 -0.15 / -0.166339K / 389KAugust 7, 2020 -0.17 / -0.14299K / 357.8KMay 14, 2020 -0.19 / -0.18589K / 653.6Kview more
Historical Data Date Price Open High Low Vol Change ER Mar 10, 2021 4.92 4.96 4.99
4.75
2.42M 0.82% Mar 9, 2021 4.88 4.76 4.98
4.67
2.52M 4.50% Mar 8, 2021 4.67 4.66 4.89
4.60
2.24M 1.30% Mar 5, 2021 4.61 4.66 4.72
4.22
4.45M -0.86% Mar 4, 2021 4.65 4.58 4.74
4.46
3.22M 1.31% Mar 3, 2021 4.59 4.76 4.84
4.59
2.24M -1.92% Mar 2, 2021 4.68 4.90 4.96
4.67
3.34M -5.45% Mar 1, 2021 4.95 4.60 5.04
4.54
2.73M 7.84% Feb 26, 2021 4.59 4.65 4.71
4.44
2.05M -0.22% Feb 25, 2021 4.60 4.73 4.91
4.59
1.94M -5.25% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company Founded:2010 Employees:115 News
Kadmon Announces U.S. FDA Has Extended the Review Period for Belumosudil in Chronic Graft-Versus-Host Disease finance.yahoo.com Mar 11, 2021 6:04 am FDA extends review period for Kadmon's belumosudil NDA seekingalpha.com Mar 11, 2021 5:20 am How Many Kadmon Holdings, Inc. (NASDAQ:KDMN) Shares Did Insiders Buy, In The Last Year? finance.yahoo.com Mar 8, 2021 5:04 pm Kadmon Holdings, Inc. (KDMN) Reports Q4 Loss, Tops Revenue Estimates nasdaq.com Mar 5, 2021 5:04 pm Kadmon EPS misses by $0.01, beats on revenue seekingalpha.com Mar 5, 2021 6:34 am
Kadmon Holdings, Inc. (KDMN) Reports Q4 Loss, Tops Revenue Estimates finance.yahoo.com Mar 4, 2021 8:45 pm
Kadmon Announces Appointment of Dr. Simon Cooper as Chief Medical Officer finance.yahoo.com Mar 1, 2021 8:00 am The Kadmon Holdings (NASDAQ:KDMN) Share Price Is Up 34 ... simplywall.st Feb 25, 2021 5:04 pm Kadmon Looks Highly Investable Before PDUFA seekingalpha.com Feb 18, 2021 5:04 pm
Kadmon Announces Closing of $240 Million Convertible Senior Notes Offering Including Full Exercise of $40 Million Over-Allotment Option finance.yahoo.com Feb 16, 2021 4:01 pm Kadmon stock down after pricing $200M convertible debt offering seekingalpha.com Feb 12, 2021 2:04 am Where Does Wall Street Think Kadmon Holdings Inc (KDMN) Stock Will Go? investorsobserver.com Feb 11, 2021 5:04 pm Is Kadmon Holdings Inc (KDMN) Stock a Great Value? investorsobserver.com Feb 11, 2021 5:04 pm Kadmon Announces Proposed $150 Million Convertible Senior Notes Offering with Capped Call Transactions finance.yahoo.com Feb 11, 2021 5:04 pm Kadmon dips after $150M convertible notes offering proposal seekingalpha.com Feb 11, 2021 6:43 am Kadmon Holdings Inc (KDMN) Up 7.94% in Premarket Trading investorsobserver.com Feb 6, 2021 8:47 am
Kadmon Announces Publication of Preclinical Data Demonstrating Anti-PD-L1/IL-15 Fusion Protein KD033 Achieves Robust Anti-Tumor Response finance.yahoo.com Feb 1, 2021 8:00 am Kadmon Holdings, Inc. (NASDAQ:KDMN) Analysts Just Trimmed Their Revenue Forecasts By 27% nasdaq.com Jan 28, 2021 8:47 am Bearish: Analysts Just Cut Their Kadmon Holdings, Inc ... simplywall.st Jan 21, 2021 8:47 am This company doesn't provide a dividend.
Key Persons CEO : Harlan W. Waksal (Aug 2014–) Talk about Kadmon Holdings Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Graham's philosophy of "value investing" has made The Intelligent Investor the stock market bible ever since its original publication in 1949.
The best book on investing ever written.
